Fundraising Fox
Cerapedics
Westminster, US · Delaware corporation · 2 known investors
Find your way into Cerapedics
466 people in our graph share verified history with the Cerapedics team — schools, employers, funds. One of them is your warm intro.
Witney McKiernanunlockedknows Glen Kashuba · together at KCK Medtech (overlapped)
×2knows the team · via Veniti Medical Inc.
×2knows the team · via DePuy Acromed Inc., Depuy Inc
×6knows the team · via Johnson & Johnson
knows the team · via Revival Healthcare Capital
Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
Founders & leadership
BP
Britt PearsonPrincipal Consultant (via Veideland Consulting)2016–2017Executive Officer at Cerapedics, which develops FDA-approved bone graft products for spinal fusion procedures. Pearson has held leadership roles in finance, operations, and strategy across biotech, high-tech, and government sectors, with expertise in process optimization, financial controls, and regulatory compliance; she holds a CPA and a B.S. in Business and Accounting from the University of Oregon.
GK
Glen KashubaChief Executive Officer, Board Member2013–2022Glen Kashuba has held CEO positions at HIGHRIDGE Medical and Cerapedics, and served as Divisional President at Johnson & Johnson and Zimmer Biomet across orthopedics, neurosurgery, and cardiology markets, with over 38 years in medical devices.
AH
Andrew HandwerkerExecutive
PJ
Paul J. MrazExecutive
Board
JS
SS
Samuel S. WuBoard director
NK
Noah KroloffBoard director
KS
Ken S. AbramowitzBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$65M disclosed across 5 rounds · 2012–2022
▶$25MraisedMar 2022 · 6 investors · BiotechnologyRule 506(b)
▶$25MraisedMar 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nael KassarDirector
- Glen KashubaExecutive Officer, Director
- Ken AbramowitzDirector
- Antony KoblishDirector
- John TattoryExecutive Officer
- Greg GarfieldDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Jeffrey G. MarxExecutive Officer
- Tyrell RiversDirector
- Valeska SchroederDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJul 2018 · 2 investors · BiotechnologyRule 506(b)
▶$22MraisedJul 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glen KashubaExecutive Officer, Director
- Chau KhuongDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Antony KoblishDirector
- Drew TrivisonnoExecutive Officer
- Tyrell RiversDirector
- Jeffrey G. MarxExecutive Officer
- Ken AbramowitzDirector
- Offering amount
- $22M
- Amount sold
- $22M
- Sales commissions
- $1.2M
- Placement agents
- Easterly Securities LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedSep 2016 · 8 investors · BiotechnologyRule 506(b)
▶$11MraisedSep 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noah KroloffDirector
- Antony KoblishDirector
- Jonathan SilversteinDirector
- Britt PearsonExecutive Officer
- Andrew J. TofeDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Jerome ConnorExecutive Officer
- Chau KhuongDirector
- Samuel S. WuDirector
- Offering amount
- $14M
- Amount sold
- $11M
- Sales commissions
- $500K
- Placement agents
- Leerink Partners LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedFeb 2015 · 5 investors · BiotechnologyRule 506(b)
▶$4MraisedFeb 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. TofeDirector
- Britt PearsonExecutive Officer
- Jonathan SilversteinDirector
- Chau KhuongDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Samuel S. WuDirector
- Jerome ConnorExecutive Officer
- Noah KroloffDirector
- Antony KoblishDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedFeb 2012 · 3 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2012 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SilversteinDirector
- Chen SchorDirector
- Andrew J TofeDirector
- Ken S. AbramowitzDirector
- Andrew HandwerkerExecutive Officer
- Leonard HabasDirector
- Paul J. MrazExecutive Officer, Director
- Chau KhuongDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Cerapedics went on to found or lead other companies.
Competitors · 4
by search overlap
Rf Surgical20 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Nuvasive14 shared keywordsNuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.
Genhealth13 shared keywordsGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Globus Medical10 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Companies competing with Cerapedics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cerapedics do?
- Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
- Who founded Cerapedics?
- Cerapedics was founded by Andrew J. Tofe.
- Who are Cerapedics's investors?
- Cerapedics's investors include Revelation Partners, OrbiMed.
- How much funding has Cerapedics raised?
- Cerapedics has disclosed $65M raised across 5 rounds.
- Where is Cerapedics headquartered?
- Cerapedics is headquartered in Westminster, US.